Royal Bank of Canada’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-41,221
Closed -$22K 6570
2019
Q4
$22K Buy
41,221
+40,793
+9,531% +$21.8K ﹤0.01% 5225
2019
Q3
$2K Sell
428
-39,772
-99% -$186K ﹤0.01% 5689
2019
Q2
$267K Buy
+40,200
New +$267K ﹤0.01% 3743
2019
Q1
Sell
-7
Closed 6084
2018
Q4
$0 Sell
7
-148
-95% ﹤0.01% 6378
2018
Q3
$3K Buy
155
+124
+400% +$2.4K ﹤0.01% 5863
2018
Q2
$1K Buy
31
+26
+520% +$839 ﹤0.01% 5851
2018
Q1
$0 Sell
5
-122
-96% ﹤0.01% 6188
2017
Q4
$10K Buy
+127
New +$10K ﹤0.01% 5131